MIT announces the publication of major research report of its symbol MDLH

NewsGuard 100/100 Score

Medical International Technology (MIT) Inc. (MDLH.OB) www.mitneedlefree.com is pleased to announce the publication of a major research report of its symbol MDLH by Grass Roots Research and Distribution, Inc.

Grass Roots Research and Distribution, Inc reports that a unique product portfolio, superior technology and a proven business model are key growth drivers for Medical International Technology Inc. The report forecasts that the Company's Fiscal Year End (FYE) October 31, 2010 will grow to $2.3 million and to more than $100.9 million by FYE 2015.

Grass Roots Research and Distribution, Inc, based on certain assumptions of the company's budget targets, expects Medical International Technology Inc. to represent an exciting long-term investment opportunity.

For full report, please visit: http://www.cohenresearch.com/Images/107_02_15_2010.pdf

"We are extremely pleased with this research report and its positive outlook on MIT's technology and potential growth" said Mr. Karim Menassa, President and CEO of Medical International Inc. "We firmly believe that our partnership and business relationship with China and other world markets will propel our revenue growth and increase shareholders value."

Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

Source:

MEDICAL INTERNATIONAL TECHNOLOGIES INC.

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings